OSTEAL THERAPEUTICS
Osteal Therapeutics, Inc. is a privately held company located in Solana Beach, CA. Founded in 2013, JPS is dedicated to providing novel drug and device combination products for treating musculoskeletal infection.
OSTEAL THERAPEUTICS
Industry:
Biotechnology Health Care Medical Medical Device Pharmaceutical
Founded:
2013-01-01
Address:
San Clemente, California, United States
Country:
United States
Website Url:
http://www.ostealtx.com
Total Employee:
1+
Status:
Active
Contact:
650-691-5030
Total Funding:
39.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Google Apps For Business GStatic Google Static Content Sectigo SSL Sectigo Domain SSL Wix
Similar Organizations
Kencor Health
Silicon Valley based healthcare company focusing on Care Coordination
Reneo Pharmaceuticals
Reneo Pharmaceuticals is an operator of a pharmaceutical company used to develop therapies for patients with orphan metabolic diseases.
Novan
Novan is a clinical-stage drug development company developing deliverable nitric oxide.
Nanoform Therapeutics
Nanoform Therapeutics develops new generation of Bio-Pharmaceutical developmental or marketed drugs.
Nora Therapeutics
Nora Therapeutics is a specialty biopharmaceutical company developing therapeutics to address clinical unmet needs in reproductive medicine.
Neurelis
Neurelis is a specialty pharmaceutical company providing a highly differentiated approach to target unmet medical needs.
Medexus Pharma
Medexus Pharma is a fully integrated specialty pharmaceutical company located in Chicago.
Mineralys Therapeutics
Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.
MIVI Neuroscience
MIVI Neuroscience focuses on developing and commercializing clinical solutions for neurointerventional procedures.
Metacrine
Metacrine is a clinical-stage bio pharmaceutical company focused on building an innovative pipeline of best-in-class drugs.
MediPrint Ophthalmics
MediPrint Ophthalmics is a clinical stage eye care pharmaceutical company.
Lipid Pharmaceuticals
Lipid Pharmaceuticals is a clinical-stage, privately held, pharmaceutical development company.
AEROGEN PHARMA
AEROGEN PHARMA is a clinical-stage specialty pharmaceutical company developing proprietary inhaled medications.
Apnimed
Apnimed is a clinical-stage company dedicated to the discovery of novel pharmacologic therapies for sleep apnea and related disorders.
AurKa Pharma
AurKa Pharma Inc. is a special purpose company created to develop one compound to proof-of-concept.
Airway Therapeutics
Airway Therapeutics focuses on pulmonary research program of Cincinnati Children’s Hospital Medical Center for further development.
Abfero Pharmaceuticals
Abfero Pharmaceuticals is a clinical stage pharmaceutical company that specializes in healthcare and medical industry.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Electra Therapeutics
Electra Therapeutics is a clinical stage biotechnology company developing therapies for cancer and other immunological diseases.
EpiEndo Pharmaceuticals
EpiEndo Pharmaceuticals is a clinical biopharmaceutical company focused on novel solutions for chronic airway diseases.
Eliem Therapeutics
Eliem Therapeutics is a clinical-stage biotechnology company developing treatments for nervous system disorders.
Babson Diagnostics
Babson Diagnostics is a medical technology company dedicated to bringing diagnostic blood testing to the retail pharmacy counter.
Fresenius Medical Care North America
Fresenius Medical Care North America provides healthcare services to people with renal and other chronic conditions.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
QuVa Pharma
QuVa Pharma is a quality-compliant manufacturer of compounded and ready-to-administer sterile injectable products.
Karyopharm Therapeutics
Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing drugs for the treatment of cancer and other major diseases.
Koya Medical
Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases.
WuXi Diagnostics
WuXi Diagnostics is the first enabling platform company in China to practice integrated diagnosis.
Stallergenes Greer
Stallergenes Greer is a fully integrated global biopharmaceutical company specialising in the diagnosis and treatment of allergies.
Palisade Bio
Palisade Bio is a clinical-stage biopharmaceutical company developing novel therapies for acute and chronic gastrointestinal complications.
Synapse Medicine
Synapse Medicine provides medication decision solutions to deliver enhanced patient-centered insights for care teams.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Spiral Therapeutics
Spiral Therapeutics is a clinical-stage pharmaceutical company delivering therapies for hearing loss.
Spectral AI
Spectral AI specializes in predictive analytics with a platform that uses proprietary artificial intelligence (AI).
Spencer Health Solutions
Spencer Health Solutions is a developer of an in-home medication dispenser.
Harrison.ai
Harrison.ai is a clinician-led healthcare AI company using deep learning to improve the odds of IVF success for thousands of patients.
Iterum Therapeutics
Iterum Therapeutics is a clinical-stage pharmaceutical company that develops significantly differentiated anti-infectives.
Gelmetix
Gelmetix is a medical device company developing a polymer treatment for chronic lower-back pain.
Vero Biotech
Vero Biotech is a biopharmaceutical company that commercializes inhaled nitric oxide delivery systems for healthcare providers.
Oculis
Oculis is a clinical-stage, privately held, pharmaceutical development company focusing on ophthalmic drugs and novel drug delivery.
Opus Medical Therapies
Opus Medical Therapies is developing transcatheter mitral and tricuspid valve replacement products.
Onkos Surgical
Onkos Surgical is a surgical oncology company that develops implants and instruments for musculoskeletal tumor patients.
OrthoSensor
OrthoSensor is a medical device company developing devices and data services for the orthopedic sector.
Orthocon
ORTHOCON is a medical therapeutics company developing absorbable products for orthopaedic and spine surgeries.
Conformal Medical
Conformal Medical is an early stage medical device company developing devices to prevent stroke in patients.
Cryosa
CryOSA is a medical device company developing novel treatments for obstructive sleep apnea.
Checkmate Pharmaceuticals
Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.
Provention Bio
Provention Bio is a clinical stage biopharmaceutical dedicated to sourcing, developing and commercializing novel therapeutics.
Calliditas Therapeutics
Calliditas Therapeutics is a specialty pharmaceutical company that develops pharmaceutical products in fields of unmet medical needs.
PharmaCyte Biotech
PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer.
Pathology Watch
Pathology Watch delivers an intuitive and easy-to-implement digital pathology solution for dermatologists.
Current Advisors List
Current Employees Featured
Founder
Investors List
HM Capital
HM Capital investment in Series B - Osteal Therapeutics
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation investment in Series B - Osteal Therapeutics
Medvest Capital
Medvest Capital investment in Series B - Osteal Therapeutics
MedVest Fund II
MedVest Fund II investment in Series A - Osteal Therapeutics
Johnson & Johnson Innovation
Johnson & Johnson Innovation investment in Series A - Osteal Therapeutics
Official Site Inspections
http://www.ostealtx.com Semrush global rank: 7.27 M Semrush visits lastest month: 548
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Osteal Therapeutics"
About Us - Osteal Therapeutics
Osteal Therapeutics is a privately-held, clinical-stage pharmaceutical company developing novel musculoskeletal therapeutics to treat orthopedic infections and their consequences.See details»
Osteal Therapeutics 2023 Rising Star | Osteal Therapeutics
Sep 21, 2023 The company’s lead candidate, VT-X7, is in Phase 2 development to treat periprosthetic joint infections, a serious complication of joint replacement surgery. For more …See details»
Osteal Therapeutics - LinkedIn
Osteal Therapeutics is a privately-held, clinical-stage pharmaceutical company developing novel musculoskeletal therapeutics to treat orthopedic infections and their consequences.See details»
Osteal Therapeutics Announces Leadership Team Appointments
Dec 29, 2022 “We now have the right leadership and expertise to deliver on our ambitious 2023 plan and build a world-class organization bringing change to a condition that hasn’t seen …See details»
David Thompson President & CEO - Musculoskeletal New …
Osteal Therapeutics is a privately held, late clinical-stage developer of novel drug/device combination therapeutics to treat orthopedic infections and their consequences. The company …See details»
Osteal Therapeutics Announces Leadership Team Appointments
Dec 29, 2022 Four new executives from the life science industry each bring over twenty years of experience in the development, approval and commercialization of high impact …See details»
Osteal Therapeutics Announces First Subject Enrollment in Second …
Feb 7, 2023 The company’s lead candidate, VT-X7, is in Phase 2 development to treat periprosthetic joint infections, a serious complication of joint replacement surgery. For more …See details»
Osteal Therapeutics’ VT-X7 Receives FDA’s Breakthrough
Dec 5, 2023 The company’s lead candidate, VT-X7, is in late-stage clinical development to treat periprosthetic joint infections, a serious complication of joint replacement surgery. For more …See details»
Osteal Therapeutics’ VT-X7 Receives FDA’s Breakthrough Therapy ...
Dec 5, 2023 Osteal Therapeutics. Breakthrough Therapy Designation for VT-X7 builds upon previous Orphan Drug, Qualified Infectious Disease Product (QIDP) and Fast Track DesignationsSee details»
Contact - Osteal Therapeutics
Osteal Therapeutics is a privately-held, clinical-stage pharmaceutical company developing novel musculoskeletal therapeutics to treat orthopedic infections and their consequences.See details»
Osteal Therapeutics Closes $50M Series D Financing to Support …
Jun 5, 2024 Financing led by Zimmer Biomet with participation from existing investors Johnson & Johnson Innovation – JJDC, Inc., Gideon Strategic Partners, and HM Capital. Proceeds will …See details»
APEX phase 2 clinical trial - Osteal Therapeutics
11/4/22. Osteal Therapeutics, Inc. Completes Enrollment in APEX Phase 2 Clinical Trial of VT-X7 for Periprosthetic Joint Infection Six-month outc omes are expected in second quarter of …See details»
Osteal Therapeutics, Inc. Completes Enrollment in APEX
DALLAS, Nov. 04, 2022 (GLOBE NEWSWIRE) -- Osteal Therapeutics, Inc. (“Osteal”), a clinical-stage biopharmaceutical company developing a new category of combination therapies for ...See details»
Osteal Therapeutics Closes an Oversubscribed $30 Million Series B ...
Mar 8, 2022 Osteal Therapeutics. Series B financing led by HM Capital and joined by returning investors JJDC and Medvest Capital. Proceeds will support clinical development of lead …See details»
Osteal Therapeutics Announces Leadership Team Appointments
DALLAS, Dec. 29, 2022 (GLOBE NEWSWIRE) -- Osteal Therapeutics, Inc. (“Osteal”), a clinical-stage biopharmaceutical company developing a new category of combination products for …See details»
Careers - Osteal Therapeutics
These fraudulent offers are being sent by individual(s) or organization(s) impersonating Osteal Therapeutics’ recruiters or representatives. As part of the scam, these fraudulent …See details»
Osteal Therapeutics’ VT-X7 Receives FDA’s Breakthrough
Dec 5, 2023 Osteal Therapeutics’ VT-X7 Receives FDA’s Breakthrough Therapy Designation for the treatment of periprosthetic joint infection of the hip and knee and completes enrollment of …See details»
Privacy Policy - Osteal Therapeutics
The content, organization, graphics, design, compilation, digital conversion and other matters related to the Site are protected under applicable copyrights, trademarks and other proprietary …See details»
Osteal Therapeutics Closes $50M Series D Financing to
Jun 5, 2024 Osteal Therapeutics secured $50M in Series D financing led by Zimmer Biomet. The funds will advance VT-X7, a treatment for periprosthetic joint infection....See details»